Clinical Efficacy of Cladribine Tablets in Patients with Highly Active Relapsing Multiple Sclerosis: 36-Month Interim Results from the Extension Trial to the MAGNIFY-MS Study

Authors
Category Primary study
ConferenceACTRIMS Forum 2024
Year 2024
This article has no abstract
Epistemonikos ID: 762a19bf8fb6beaac59079174b79e1cdd4637e43
First added on: Dec 05, 2025